MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

AMAG Pharmaceuticals Company Profile (NASDAQ:AMAG)

Consensus Ratings for AMAG Pharmaceuticals (NASDAQ:AMAG) (?)
Ratings Breakdown: 5 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $39.33 (67.95% upside)

Analysts' Ratings History for AMAG Pharmaceuticals (NASDAQ:AMAG)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Deutsche BankLower Price TargetHold$42.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016JPMorgan Chase & Co.Reiterated RatingHold$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Leerink SwannLower Price TargetOutperform$45.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Raymond JamesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Robert W. BairdLower Price TargetOutperform$26.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016GuggenheimLower Price TargetBuy$54.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016Northland SecuritiesInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2016BarclaysInitiated CoverageEqual Weight$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015FBR & Co.Reiterated RatingMarket Perform$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for AMAG Pharmaceuticals (NASDAQ:AMAG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/21/2016        
5/3/2016Q116$1.11$0.94$124.83 million$117.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2016Q415$1.16$1.12$120.13 million$108.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315$1.21$1.02$113.88 million$103.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215$0.75$1.12$94.05 million$123.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115$1.04$1.11$84.66 million$89.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2015Q414$0.30$0.06$52.69 million$53.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.08)$0.06$26.30 million$25.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214($0.09)($0.07)$23.40 million$24.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q1($0.07)($0.33)$22.73 million$20.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q4($0.10)($0.17)$21.01 million$21.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013Q313($0.12)($0.01)$20.37 million$21.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013($0.17)($0.09)$18.51 million$19.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2013Q1 2013($0.20)($0.18)$17.99 million$17.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2013Q4 2012($0.06)($0.17)$22.54 million$21.14 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312($0.26)($0.19)$20.43 million$17.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.39)$0.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.63)($0.58)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2012($1.09)($0.87)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2011($0.98)($0.78)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.99)($1.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2011($1.04)($0.94)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for AMAG Pharmaceuticals (NASDAQ:AMAG)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.13$0.68$0.36
Q2 20163$0.14$0.76$0.54
Q3 20165$0.22$0.90$0.53
Q4 20163$0.60$1.06$0.89
(Data provided by Zacks Investment Research)
Dividend History for AMAG Pharmaceuticals (NASDAQ:AMAG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for AMAG Pharmaceuticals (NASDAQ:AMAG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
11/10/2015John A FallonDirectorBuy3,230$31.20$100,776.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015William K HeidenCEOSell2,000$39.69$79,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015William K HeidenCEOSell2,000$61.19$122,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015William K HeidenCEOSell20,000$75.00$1,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Scott A HolmesSVPSell7,580$66.63$505,055.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015William K HeidenCEOSell66,875$69.90$4,674,562.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Frank E ThomasCOOSell20,000$69.47$1,389,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Scott A HolmesSVPSell22,516$68.88$1,550,902.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Adage Capital Partners Gp LlcMajor ShareholderSell1,250,000$46.49$58,112,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Christopher WhiteInsiderSell4,000$22.37$89,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Christopher WhiteInsiderSell5,000$23.90$119,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for AMAG Pharmaceuticals (NASDAQ:AMAG)
DateHeadline
06/25/16 02:27 PMAmag Pharmaceuticals Incorporated (NASDAQ:AMAG) Sellers Covered 3.07% of Their Shorts - Engelwood Daily
06/24/16 09:38 AMPrice Target Update on AMAG Pharmaceuticals (NASDAQ:AMAG) - Trade Calls
06/23/16 09:51 PMWhat Will Happen to AMAG Pharmaceuticals, Inc. Next? The Stock Just Declined A Lot - Press Telegraph
06/23/16 10:14 AMHealthcare Sector Equities Under the Scanner - Alkermes, AMAG Pharma, IDEXX Laboratories, and Aduro BioTech - PR Newswire (press release)
06/23/16 10:14 AMCan AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Keep Up with Analyst Expectations? - Investor Newswire
06/22/16 07:15 AMAMAG Pharmaceuticals (NASDAQ:AMAG) Analyst Rating Consensus - TheFounders Daily
06/20/16 02:25 PMCompany Shares of AMAG Pharmaceuticals Rally 10.41% - Trade Calls
06/19/16 07:11 AMAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 10:51 AMAMAG Pharmaceuticals, Inc. – Value Analysis (NASDAQ:AMAG) : June 17, 2016 -
06/15/16 07:14 AMAMAG Pharmaceuticals Inc. (AMAG) Jumps 5.39% on June 14 - Equities.com
06/15/16 07:05 AMAMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMAG-US : June 15, 2016 -
06/15/16 07:05 AMAMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMAG-US : June 15, 2016 -
06/14/16 02:26 PMThe Insider Activity Don't Lie: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - iStreetWire
06/13/16 10:32 AMMost Recent Stocks Movements: Grifols, S.A. (NASDAQ:GRFS) , AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Street Updates
06/12/16 02:26 PMWhy AMAG Pharmaceuticals, Inc. Plunged 19.2% in May - Motley Fool
06/12/16 07:43 AMWhy AMAG Pharmaceuticals, Inc. Plunged 19.2% in May -
06/10/16 02:28 PMI.V. Iron (Intravenous) Drugs Market 2016 Edition: Key Major Players Are Galenica Group, AMAG Pharmaceuticals & Allergan
06/10/16 02:28 PMGlobal intravenous (iv) iron drugs industry key trends, growth drivers, regional analysis and 2016-2018 forecast research illuminated by new report
06/10/16 02:28 PMI.V. (Intravenous ) Iron Drugs Regional Market Analysis & 2019 Forecasts – MarketReportsOnline.com
06/09/16 11:19 AMPreview of Stock's Movement: Sanofi (NYSE:SNY) , AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Street Updates
06/08/16 01:21 PMHow Does Incyte’s Valuation Compare to Its Peers? -
06/06/16 07:39 PMAMAG PHARMACEUTICALS INC. (NASDAQ:AMAG) Financial Condition Compared to S&P 500 - CML News
06/05/16 02:26 PMAMAG Pharmaceuticals, Inc. (AMAG) Downgraded by Raymond James to “Market Perform” - Let Me Know About This
06/05/16 10:19 AMAfter Last Week What Do Analysts Think Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Share Trading News
06/03/16 08:30 PMJefferies Group Reiterates Buy Rating for AMAG Pharmaceuticals, Inc. (AMAG) - Let Me Know About This
06/02/16 11:04 AMAnalyst Earnings Report: CytRx Corporation (NASDAQ:CYTR), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Beacon Chronicle - Beacon ChronicleAnalyst Earnings Report: CytRx Corporation (NASDAQ:CYTR), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)Beacon ChronicleLast Trade: The Company closed its last session at $2.93 with the loss of -2.01%. The market capitalization of the company is $193.5 Million, with the average Volume of 872.91K. The stock currently has its 52-Week High range of $4.29 and 52-week low ...and more »
06/01/16 10:51 AMAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Quarterly EPS Estimate At $1.44 - Investor Newswire - AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Quarterly EPS Estimate At $1.44Investor NewswireFirst Call stated that AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) can touch $45.13 in coming one year. For the next quarter, the per-share earnings target is $1.44 and for ongoing fiscal at $5.23. EPS target for next year is $6.25 versus the mean EPS of ...and more »
06/01/16 06:03 AMAMAG PHARMACEUTICALS INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
05/31/16 08:25 AMStock Review and Earnings Check on AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - HNN - Stock Review and Earnings Check on AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting AMAG Pharmaceuticals, Inc.and more »
05/31/16 08:25 AMStocks within investor Spotlight: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , AMAG Pharmaceuticals, Inc ... - Street Updates - Stocks within investor Spotlight: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , AMAG Pharmaceuticals, Inc ...Street UpdatesIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) accumulated +1.23%, closing at $12.38 after floating between $12.22 and $12.40. The company has market capitalization of $1.79B. It has twelve month low of $7.35 and twelve month high of $14.28.
05/30/16 11:52 AMTarget Check and Stock Performance Recap AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - HNN - Target Check and Stock Performance Recap AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)HNNTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, AMAG Pharmaceuticals, Inc.and more »
05/27/16 11:21 AMHealthcare Stocks Buzz: AMAG Pharmaceuticals, Inc.(NASDAQ:AMAG), Amgen, Inc.(NASDAQ:AMGN) - NYSE Journal (press release) - Healthcare Stocks Buzz: AMAG Pharmaceuticals, Inc.(NASDAQ:AMAG), Amgen, Inc.(NASDAQ:AMGN)NYSE Journal (press release)On Thursday, Shares of AMAG Pharmaceuticals, Inc.(NASDAQ:AMAG), added 0.54% and closed at $20.36 in the last trading session. The last trading range of the stock ranges between $19.72 and $20.48. AMAG Pharmaceuticals, Inc. (AMAG) recently ...and more »
05/27/16 11:21 AMValuable Price Trends to Observe: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) , Orexigen Therapeutics, Inc ... - Street Updates - Valuable Price Trends to Observe: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) , Orexigen Therapeutics, Inc ...Street UpdatesOn 5/26/2016, shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rose +0.54% in trading session and finally closed at $20.36. The company most recent volume stood at 758.41 thousand shares as compared to its average volume of 1.28 million shares.and more »
05/27/16 11:21 AMAMAG Pharmaceuticals Inc. reports 1st-quarter highlights - MetroWest Daily News - AMAG Pharmaceuticals Inc. reports 1st-quarter highlightsMetroWest Daily NewsWALTHAM — AMAG Pharmaceuticals Inc., a Waltham-based specialty pharmaceutical company, reported unaudited consolidated financial results for the first quarter ended March 31. Most notably, the first quarter of 2016 included the approval of a ...
05/26/16 10:23 AMStock Rating Review for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Wall Street Hints and News - Stock Rating Review for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1.89 on shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research.and more »
05/26/16 10:23 AMMarket Buzzers Update: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) , AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - Street Updates - Market Buzzers Update: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) , AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)Street UpdatesAMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) after beginning at $18.85, closed at $19.67 by building up +4.41% in recent trading session. Most recent session's volume of 844.61 thousand shares lower than its average volume of 1.32 million shares.and more »
05/25/16 07:54 AMShould You Get Rid of AMAG Pharmaceuticals (AMAG) Now? -
05/25/16 07:06 AMAMAG Pharmaceuticals to Present at Upcoming Investor Conferences - [at noodls] - WALTHAM, Mass., May 25, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG's business and financial outlook, strategy and growth ...
05/20/16 03:24 PMAMAG PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V -
05/19/16 05:56 PMETF’s with exposure to AMAG Pharmaceuticals, Inc. : May 19, 2016 -
05/19/16 07:32 AMAMAG Pharmaceuticals Announces 2016 Analyst Day - [at noodls] - WALTHAM, Mass., May 19, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia ...
05/05/16 03:49 PMETF’s with exposure to AMAG Pharmaceuticals, Inc. : May 5, 2016 -
05/05/16 08:23 AMAMAG PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report -
05/04/16 10:29 AMAMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/26/16 11:38 AMAMAG Pharmaceuticals to host conference call - MetroWest Daily News - AMAG Pharmaceuticals to host conference callMetroWest Daily NewsAMAG Pharmaceuticals Inc., a Waltham-based biopharmaceutical company, will report unaudited consolidated financial results for the first quarter ending March 31 before the U.S. financial markets open on May 3. The announcement will be followed by a ...
04/26/16 11:38 AMStocks Under Review: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) - News Oracle - Stocks Under Review: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)News OracleLast Trade: The Company rose 3.73% and finished at $28.91. The daily volume was measured at 1.25 million shares. The 52-week high of the share price is $77.73 and the 52-week low is $20.22. The company has a market cap of $1.08 billion. The stock has ...and more »
04/21/16 07:14 AMAMAG Pharmaceuticals to Host Conference Call on May 3, 2016 at 8:00 a.m. ET to Discuss Financial Results for the First Quarter Ended March 31, 2016 - [at noodls] - WALTHAM, Mass., April 21, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will report unaudited consolidated financial results for the first quarter ended March 31, ...
04/11/16 03:08 PMAMAG PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh -
04/06/16 08:30 AMThe Zacks Analyst Blog Highlights: Edwards Lifesciences, PRA Health Sciences, Gilead Sciences, AMAG Pharmaceuticals and Horizon Pharma -
04/04/16 07:07 AMAMAG Pharmaceuticals Announces the U.S. Commercial Launch of New Single-Dose, Preservative-Free Makena® (hydroxyprogesterone caproate injection) - [at noodls] - WALTHAM, Mass., April 04, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the new single-dose, preservative-free Makena® is now available for prescribing. Makena ...
About AMAG Pharmaceuticals

AMAG Pharmaceuticals logoAMAG Pharmaceuticals, Inc. is a pharmaceutical company. The Company's segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units operated through Cord Blood Registry (CBR); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Diagnostic Substances
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AMAG
  • CUSIP: 00163U10
Key Metrics:
  • Previous Close: $24.89
  • 50 Day Moving Average: $21.12
  • 200 Day Moving Average: $23.99
  • P/E Ratio: 78.33
  • P/E Growth: -2.55
  • Market Cap: $809.82M
  • Current Quarter EPS Consensus Estimate: $5.20 EPS
Additional Links:
AMAG Pharmaceuticals (NASDAQ:AMAG) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha